Meloxicam long-acting injection (Nanjing Qingpu Biological Tech)

美洛昔康长效注射剂（南京清普生物）

Report date: 2026/05/15 20:01:45

Base Information

Drug NameMeloxicam long-acting injection (Nanjing Qingpu Biological Tech)
Drug Alias NameMeloxicam long-acting injection (Nanjing Qingpu Biological Tech)美洛昔康长效注射剂（南京清普生物）美洛昔康注射液（Ⅱ）QamzovaQP-001 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2
Therapy Area/IndicationsPainPain, Postoperative
Global Approved IndicationsPain
Approved Indications in ChinaPain
Original Approved Country/TerritoryUnited States
Original Approved Date2025/04/22
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNanjing Delova Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSino Biopharmaceutical LtdNanjing Delova Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsPainPain, Postoperative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A